TP53 and cancer: In addition, TP53 is affected by somatic loss-of-function mutations in a large fraction (>50%, according to current estimates) of human cancers all confounded.1 Finally, several other molecular defects causally associated with malignant transformation or tumor progression result in the functional inactivation of the p53 system.